We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Committee Backs Sanofi’s Type 2 Combination Candidate
FDA Committee Backs Sanofi’s Type 2 Combination Candidate
An FDA advisory committee recommended approval of Sanofi’s combination candidate for Type 2 diabetes Wednesday, making it the second such product backed by the committee in the last 24 hours.